MedChem Europe Provisional Agenda Released
MedChem Europe Provisional Agenda Released
Select Biosciences have again assembled a world class mixture of the best minds in this dynamic field. Over 400 attendees are expected and 50 exhibition booths will be presenting the latest technologies available. To be held 21-22 Feb 2006 in the beautiful city of Prague, this conference will provide a major networking opportunity and an un-missable event for those wishing to keep abreast of new developments in the field of medicinal chemistry.
The third Screening Europe conference will be held in parallel to this event to allow interfacing with colleagues from the closely aligned field of biomolecular screening.
Agenda sessions include:
– Drug Discovery and Optimization
Chaired by Dr. Mark Bradley
Professor of High Throughput Chemical Biology University of Edinburgh
– Information, Analysis and Data Management Chaired by Dr. Miles Congreve Associate Director Astex Therapeutics
– Enhanced Synthesis Tools in Medicinal Chemistry Chaired by Dr. C. Oliver Kappe Associate Professor of Chemistry Karl-Franzens-University Graz
For the full downloadable agenda (pdf) please visit www.MedChemEurope.com
Selected media partnerships are available for this event.
About Select Biosciences
Select Biosciences Ltd. is focused on organizing specialist biomedical meetings. Experts from both academia and commerce present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.
For further information on this conference, contact: Karen Saunders ksaunders@selectbiosciences.com
